North America Multiple Sclerosis Drugs Market Size, Share, Forecast, and Growth Opportunity
North America multiple sclerosis drugs market is expected to grow by 3.8% annually in the forecast period and reach $15.65 billion by 2027 owing to the growing prevalence of multiple sclerosis (MS), the rise in funding for multiple sclerosis research, and increasing approvals of novel MS drugs.Highlighted with 28 tables and 51 figures, this 104-page … Read more